Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio Aug 11, 2022 8:25am EDT
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies Aug 04, 2022 8:25am EDT
Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements Aug 02, 2022 8:25am EDT
Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022 Aug 01, 2022 8:25am EDT
PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America Jul 19, 2022 8:25am EDT
Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference Jul 18, 2022 8:25am EDT
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO May 13, 2022 8:25am EDT
PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results May 12, 2022 4:38pm EDT
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results May 11, 2022 4:00pm EDT
